It is not an approved dietary supplement ingredient under the Dietary Supplement Health and Education Act (DSHEA) framework because it has not been grandfathered in as a pre-DSHEA ingredient and is not a recognized vitamin, mineral, herb, or botanical
By weeks 5-8, approximately 70% of patients report significant symptom improvement
It is, therefore, important to address depression at an early stage in order to improve medication adherence and overall diabetes management
Genetic predispositions and individual neurochemistry determine the outcome
Over 70% of Americans are either overweight or have obesity, so a large percentage of the target population for addiction treatment already falls into the broad category of individuals for whom GLP-1s have well studied benefits for health and mortality
Patients will start to see the effects of Semaglutide working after the first dose and should start experiencing weight loss within the first two weeks of their program